SE9300012D0 - New peptides - Google Patents
New peptidesInfo
- Publication number
- SE9300012D0 SE9300012D0 SE9300012A SE9300012A SE9300012D0 SE 9300012 D0 SE9300012 D0 SE 9300012D0 SE 9300012 A SE9300012 A SE 9300012A SE 9300012 A SE9300012 A SE 9300012A SE 9300012 D0 SE9300012 D0 SE 9300012D0
- Authority
- SE
- Sweden
- Prior art keywords
- new peptides
- peptides
- compounds
- taining
- immunosuppressants
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/70—Enkephalins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (25)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9300012A SE9300012D0 (sv) | 1993-01-05 | 1993-01-05 | New peptides |
SK839-95A SK83995A3 (en) | 1993-01-05 | 1993-12-20 | New peptides |
EP94904365A EP0678099A1 (en) | 1993-01-05 | 1993-12-20 | New peptides |
NZ259597A NZ259597A (en) | 1993-01-05 | 1993-12-20 | Peptide analogs that are opioid receptor antagonists and their use as analgesic and immunosuppressive compounds |
CA002152380A CA2152380A1 (en) | 1993-01-05 | 1993-12-20 | New peptides |
CZ951711A CZ171195A3 (en) | 1993-01-05 | 1993-12-20 | Novel peptides |
PCT/SE1993/001090 WO1994015959A1 (en) | 1993-01-05 | 1993-12-20 | New peptides |
PL93309778A PL309778A1 (en) | 1993-01-05 | 1993-12-20 | Novel peptides |
HU9502041A HUT72597A (en) | 1993-01-05 | 1993-12-20 | New peptide, pharmaceutical compositions containing them and process for producing them |
AU58448/94A AU681372B2 (en) | 1993-01-05 | 1993-12-20 | New peptides |
JP6515914A JPH08505386A (ja) | 1993-01-05 | 1993-12-20 | 新規なペプチド |
KR1019950702750A KR960700269A (ko) | 1993-01-05 | 1993-12-20 | 신규한 펩티드(New Peptides) |
IL10816993A IL108169A0 (en) | 1993-01-05 | 1993-12-24 | New peptides |
IS4115A IS4115A (is) | 1993-01-05 | 1993-12-27 | Ný peptíð |
US08/176,938 US5602099A (en) | 1993-01-05 | 1994-01-04 | δ opioid receptor antagonists |
MX9400255A MX9400255A (es) | 1993-01-05 | 1994-01-04 | Analogos de peptidos opioides, metodo para su preparacion y composiciones farmaceuticas que los incluyen. |
ZA9455A ZA9455B (en) | 1993-01-05 | 1994-01-05 | New peptides |
YU394A YU394A (sh) | 1993-01-05 | 1994-01-05 | Novi peptidi koji deluju kao antagonisti opijatskih receptora i postupci za njihovu izradu |
SI9400005A SI9400005A (en) | 1993-01-05 | 1994-01-05 | Novel opioid peptide analogs |
APAP/P/1994/000605A AP508A (en) | 1993-01-05 | 1994-01-05 | Novel opioid analogs that are 9 (delta) opioid receptor antagonists, their syntheis and their use as analgesic and immunosupressive compounds. |
CN94100129A CN1096515A (zh) | 1993-01-05 | 1994-01-05 | 新型肽 |
EE9400326A EE9400326A (et) | 1993-01-05 | 1994-11-03 | Opioidpeptiidi analoogid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid |
LVP-95-197A LV10962B (en) | 1993-01-05 | 1995-06-29 | New peptides |
FI953302A FI953302A0 (fi) | 1993-01-05 | 1995-07-04 | Uudet peptidit |
NO952650A NO952650L (no) | 1993-01-05 | 1995-07-04 | Nye peptider |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9300012A SE9300012D0 (sv) | 1993-01-05 | 1993-01-05 | New peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9300012D0 true SE9300012D0 (sv) | 1993-01-05 |
Family
ID=20388466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9300012A SE9300012D0 (sv) | 1993-01-05 | 1993-01-05 | New peptides |
Country Status (25)
Country | Link |
---|---|
US (1) | US5602099A (cs) |
EP (1) | EP0678099A1 (cs) |
JP (1) | JPH08505386A (cs) |
KR (1) | KR960700269A (cs) |
CN (1) | CN1096515A (cs) |
AP (1) | AP508A (cs) |
AU (1) | AU681372B2 (cs) |
CA (1) | CA2152380A1 (cs) |
CZ (1) | CZ171195A3 (cs) |
EE (1) | EE9400326A (cs) |
FI (1) | FI953302A0 (cs) |
HU (1) | HUT72597A (cs) |
IL (1) | IL108169A0 (cs) |
IS (1) | IS4115A (cs) |
LV (1) | LV10962B (cs) |
MX (1) | MX9400255A (cs) |
NO (1) | NO952650L (cs) |
NZ (1) | NZ259597A (cs) |
PL (1) | PL309778A1 (cs) |
SE (1) | SE9300012D0 (cs) |
SI (1) | SI9400005A (cs) |
SK (1) | SK83995A3 (cs) |
WO (1) | WO1994015959A1 (cs) |
YU (1) | YU394A (cs) |
ZA (1) | ZA9455B (cs) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL112111A (en) * | 1993-12-23 | 2000-07-16 | Novo Nordisk As | Peptides having growth hormone releasing properties and pharmaceutical compositions containing them |
IS4261A (is) * | 1994-02-21 | 1995-08-22 | Astra Aktiebolag | Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra |
IL114046A0 (en) * | 1994-06-20 | 1995-10-31 | Astra Ab | New opioid peptide antagonists |
RU2067000C1 (ru) * | 1994-06-29 | 1996-09-27 | Владислав Исакович Дейгин | Пептид и способ его получения |
US6184208B1 (en) | 1994-06-29 | 2001-02-06 | Immunotech Developments Inc. | Peptide, a method for its preparation and a pharmaceutical composition containing the peptide |
SE9402880D0 (sv) * | 1994-08-30 | 1994-08-30 | Astra Ab | New peptide derivatives |
US5780589A (en) * | 1994-11-30 | 1998-07-14 | The United States Of America As Represented By The Department Of Health And Human Services | Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof |
EP0837857A4 (en) * | 1995-03-29 | 1998-08-05 | Merck & Co Inc | FARNESYL-PROTEIN TRANSFERASE INHIBITORS |
AU708620B2 (en) * | 1995-03-29 | 1999-08-05 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
DE19512484A1 (de) | 1995-04-04 | 1996-10-17 | Bayer Ag | Kohlenhydratmodifizierte Cytostatika |
SE9600769D0 (sv) * | 1996-02-28 | 1996-02-28 | Astra Ab | Compounds useful as analgesic |
US6903075B1 (en) | 1997-05-29 | 2005-06-07 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
EP1001764A4 (en) * | 1997-05-29 | 2005-08-24 | Merck & Co Inc | Heterocyclic amides as cell adhesion inhibitors |
US6703381B1 (en) | 1998-08-14 | 2004-03-09 | Nobex Corporation | Methods for delivery therapeutic compounds across the blood-brain barrier |
US6306576B1 (en) * | 1999-02-19 | 2001-10-23 | Cleveland Clinic Foundation | Diagnostic methods for asthma |
US7601739B2 (en) | 2003-08-08 | 2009-10-13 | Virgina Commonwealth University | Compounds having antiestrogenic and tissue selective estrogenic properties, and compounds with anti-androgenic properties for treatment of prostate cancer and androgen receptor dependent diseases |
EP1768662A2 (en) | 2004-06-24 | 2007-04-04 | Novartis Vaccines and Diagnostics, Inc. | Small molecule immunopotentiators and assays for their detection |
WO2006034343A2 (en) * | 2004-09-23 | 2006-03-30 | Alexander Michalow | methods for regulating neurotransmitter systems by inducing counteradaptationS |
US20080045610A1 (en) * | 2004-09-23 | 2008-02-21 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
WO2015200828A1 (en) * | 2014-06-27 | 2015-12-30 | H. Lee Moffit Cancer Center And Research Institute, Inc. | Conjugates for immunotherapy |
-
1993
- 1993-01-05 SE SE9300012A patent/SE9300012D0/xx unknown
- 1993-12-20 NZ NZ259597A patent/NZ259597A/en unknown
- 1993-12-20 EP EP94904365A patent/EP0678099A1/en not_active Withdrawn
- 1993-12-20 JP JP6515914A patent/JPH08505386A/ja active Pending
- 1993-12-20 SK SK839-95A patent/SK83995A3/sk unknown
- 1993-12-20 WO PCT/SE1993/001090 patent/WO1994015959A1/en not_active Application Discontinuation
- 1993-12-20 CZ CZ951711A patent/CZ171195A3/cs unknown
- 1993-12-20 HU HU9502041A patent/HUT72597A/hu unknown
- 1993-12-20 PL PL93309778A patent/PL309778A1/xx unknown
- 1993-12-20 AU AU58448/94A patent/AU681372B2/en not_active Ceased
- 1993-12-20 KR KR1019950702750A patent/KR960700269A/ko not_active Application Discontinuation
- 1993-12-20 CA CA002152380A patent/CA2152380A1/en not_active Abandoned
- 1993-12-24 IL IL10816993A patent/IL108169A0/xx unknown
- 1993-12-27 IS IS4115A patent/IS4115A/is unknown
-
1994
- 1994-01-04 MX MX9400255A patent/MX9400255A/es unknown
- 1994-01-04 US US08/176,938 patent/US5602099A/en not_active Expired - Fee Related
- 1994-01-05 SI SI9400005A patent/SI9400005A/sl unknown
- 1994-01-05 YU YU394A patent/YU394A/sh unknown
- 1994-01-05 ZA ZA9455A patent/ZA9455B/xx unknown
- 1994-01-05 CN CN94100129A patent/CN1096515A/zh active Pending
- 1994-01-05 AP APAP/P/1994/000605A patent/AP508A/en active
- 1994-11-03 EE EE9400326A patent/EE9400326A/xx unknown
-
1995
- 1995-06-29 LV LVP-95-197A patent/LV10962B/en unknown
- 1995-07-04 FI FI953302A patent/FI953302A0/fi unknown
- 1995-07-04 NO NO952650A patent/NO952650L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA9455B (en) | 1994-07-05 |
AP508A (en) | 1996-07-22 |
US5602099A (en) | 1997-02-11 |
PL309778A1 (en) | 1995-11-13 |
IL108169A0 (en) | 1994-04-12 |
FI953302A (fi) | 1995-07-04 |
AU5844894A (en) | 1994-08-15 |
SK83995A3 (en) | 1996-09-04 |
CZ171195A3 (en) | 1996-09-11 |
NO952650L (no) | 1995-08-30 |
SI9400005A (en) | 1994-12-31 |
AU681372B2 (en) | 1997-08-28 |
AP9400605A0 (en) | 1994-01-31 |
NO952650D0 (no) | 1995-07-04 |
MX9400255A (es) | 1994-07-29 |
FI953302A0 (fi) | 1995-07-04 |
CN1096515A (zh) | 1994-12-21 |
IS4115A (is) | 1994-07-06 |
NZ259597A (en) | 1996-07-26 |
EE9400326A (et) | 1996-04-15 |
WO1994015959A1 (en) | 1994-07-21 |
EP0678099A1 (en) | 1995-10-25 |
KR960700269A (ko) | 1996-01-19 |
HUT72597A (en) | 1996-05-28 |
CA2152380A1 (en) | 1994-07-21 |
LV10962A (lv) | 1995-12-20 |
HU9502041D0 (en) | 1995-09-28 |
YU394A (sh) | 1997-07-31 |
JPH08505386A (ja) | 1996-06-11 |
LV10962B (en) | 1997-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9300012D0 (sv) | New peptides | |
MX9702380A (es) | Nuevas carboxamidas con actividad antifungica. | |
FR2696094B1 (fr) | Nouvelles compositions pharmaceutiques contenant des cyclosporines. | |
DE69225588D1 (de) | Azeotropische und azeotropähnliche zusammensetzungen von 1,1,2,2,-tetrafluorathan | |
MX9703186A (es) | Antagonistas del receptor del neuropeptido y de indolilo. | |
IL94990A (en) | Pharmaceutical compositions for the prophylaxis and/or treatment of benign porstatic hyperplasia | |
TR200001012T2 (tr) | Yeni ariloksi-alkil-dialkilaminler. | |
DE69232323D1 (de) | Verwendung von Adenosinantagonisten zur Vorbeugung und Behandlung von Pankreatitis und Ulcera | |
DK0705100T3 (da) | Terapeutiske substituerede guanidiner | |
BR9607560A (pt) | Composições cométicas anidras contendo agentes dermatologicamente ativo | |
CA2237189A1 (en) | 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists | |
ID22523A (id) | Formulasi aerosol obat yang mengandung budesonida | |
ITBO970640A0 (it) | Apparecchio per l'elettroemanazione di principi attivi. | |
TR199902848T2 (xx) | Ergolin t�revleri ve bunlar�n somatostatin resept�r antagonist olarak kullan�mlar� | |
BG105256A (en) | Muscarinic agonists and antagonists | |
NO933524D0 (no) | Krystallisk tiagabinhydrokloridmonohydrat samt fremstilling og anvendelse derav | |
IT1304794B1 (it) | Miscela di stabilizzanti | |
PL337221A1 (en) | Carboxamides as antagonists of 5-ht1f | |
ATE265138T1 (de) | Retardformulierungen von pflanzenschutzwirkstoffen | |
MD502G2 (ro) | Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin | |
PL350568A1 (en) | N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors | |
NO971997D0 (no) | Bruk av immunmodulerende midler | |
MX9708394A (es) | Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion. | |
NO980296L (no) | Forbedrede terapeutiske midler | |
NO20000519L (no) | 2-acylaminopropanaminer som takykininreseptorantagonister |